Clinical Trial Update: Safety of UC-MSC Transfusion for ACLF Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety of umbilical cord-derived mesenchymal stem cell transfusion in patients with acute-on-chronic liver failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• UC-MSC transfusion (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Hai Li | Conditions: Acute-On-Chronic Liver Failure | Phase 2 | Status: UNKNOWN